KDR and colorectal carcinoma: CRC is a disease strongly linked to dysregulation of the VEGF-VEGFR axis, with therapies aimed at targeting both soluble VEGF-A (Los et al., 2007) and membrane-bound VEGFRs (Morabito et al., 2006).